Canada Pension Plan Investment Board Invests $1.23 Million in National Health Investors, Inc. $NHI

Key Points

• Canada Pension Plan Investment Board initiated a $1.23 million position in National Health Investors during the second quarter. Institutional investors collectively own 62.51% of NHI’s shares.
• Analysts maintain a consensus “Moderate Buy” rating, with an average price target of $83.86 versus the stock’s reported price of $71.26. However, several firms recently lowered their targets, and Zacks downgraded the stock to “strong sell.”
• NHI reported quarterly EPS of $1.19 on $121.32 million in revenue and declared a $0.92 quarterly dividend, equivalent to a 5.2% yield. CEO D. Eric Mendelsohn and Director Robert A. McCabe Jr. also recently purchased shares.

Canada Pension Plan Investment Board bought a new position in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 16,100 shares of the real estate investment trust's stock, valued at approximately $1,228,000.

Several other hedge funds and other institutional investors have also bought and sold shares of NHI. International Assets Investment Management LLC bought a new stake in National Health Investors during the fourth quarter valued at $27,000. EverSource Wealth Advisors LLC raised its position in shares of National Health Investors by 244.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust's stock worth $28,000 after acquiring an additional 288 shares in the last quarter. Garton & Associates Financial Advisors LLC bought a new position in shares of National Health Investors in the 4th quarter worth about $33,000. Allworth Financial LP acquired a new position in shares of National Health Investors in the 2nd quarter valued at about $42,000. Finally, Advisory Services Network LLC acquired a new position in shares of National Health Investors in the 3rd quarter valued at about $65,000. Institutional investors and hedge funds own 62.51% of the company's stock.

Analyst Ratings Changes

NHI has been the subject of several recent analyst reports. Truist Financial decreased their target price on National Health Investors from $89.00 to $81.00 and set a "buy" rating for the company in a research note on Friday, June 12th. Deutsche Bank Aktiengesellschaft dropped their price target on National Health Investors from $85.00 to $80.00 and set a "hold" rating on the stock in a research note on Thursday, June 25th. BMO Capital Markets cut their price target on National Health Investors from $90.00 to $80.00 and set an "outperform" rating on the stock in a report on Monday, June 15th. Wells Fargo & Company reduced their price objective on shares of National Health Investors from $84.00 to $79.00 and set an "equal weight" rating for the company in a research report on Monday, June 1st. Finally, Zacks Research lowered shares of National Health Investors from a "hold" rating to a "strong sell" rating in a research note on Thursday, June 25th. Five research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, National Health Investors currently has a consensus rating of "Moderate Buy" and an average target price of $83.86.

National Health Investors Price Performance

Shares of NYSE NHI opened at $71.26 on Tuesday. National Health Investors, Inc. has a fifty-two week low of $67.94 and a fifty-two week high of $91.38. The stock has a market cap of $3.50 billion, a price-to-earnings ratio of 20.60, a PEG ratio of 3.83 and a beta of 0.51. The company has a debt-to-equity ratio of 0.81, a quick ratio of 6.78 and a current ratio of 6.78. The firm's 50-day simple moving average is $75.69 and its 200 day simple moving average is $78.61.

National Health Investors (NYSE:NHI - Get Free Report) last issued its quarterly earnings data on Monday, August 10th. The real estate investment trust reported $1.19 EPS for the quarter. The firm had revenue of $121.32 million during the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.The business's revenue for the quarter was up 1.6% on a year-over-year basis. During the same period in the prior year, the firm posted $1.22 earnings per share. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. As a group, research analysts anticipate that National Health Investors, Inc. will post 4.78 earnings per share for the current fiscal year.

National Health Investors Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 6th. Investors of record on Wednesday, September 30th will be issued a dividend of $0.92 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.68 annualized dividend and a yield of 5.2%. National Health Investors's dividend payout ratio is 106.36%.

Insider Buying and Selling at National Health Investors

In related news, Director Robert A. Mccabe, Jr. purchased 890 shares of the stock in a transaction that occurred on Monday, June 15th. The stock was acquired at an average cost of $71.65 per share, with a total value of $63,768.50. Following the transaction, the director owned 44,159 shares of the company's stock, valued at $3,163,992.35. This represents a 2.06% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO D. Eric Mendelsohn purchased 1,500 shares of the stock in a transaction that occurred on Friday, June 5th. The stock was bought at an average cost of $68.84 per share, with a total value of $103,260.00. Following the completion of the transaction, the chief executive officer directly owned 133,316 shares in the company, valued at $9,177,473.44. The trade was a 1.14% increase in their position. The SEC filing for this purchase provides additional information. Corporate insiders own 2.70% of the company's stock.

About National Health Investors

National Health Investors, Inc NYSE: NHI is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company's portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source